1. Home
  2. OCS vs IAUX Comparison

OCS vs IAUX Comparison

Compare OCS & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • IAUX
  • Stock Information
  • Founded
  • OCS 2003
  • IAUX 2020
  • Country
  • OCS Switzerland
  • IAUX United States
  • Employees
  • OCS N/A
  • IAUX N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • IAUX
  • Sector
  • OCS Health Care
  • IAUX
  • Exchange
  • OCS Nasdaq
  • IAUX Nasdaq
  • Market Cap
  • OCS 1.0B
  • IAUX 889.5M
  • IPO Year
  • OCS N/A
  • IAUX N/A
  • Fundamental
  • Price
  • OCS $19.18
  • IAUX $0.93
  • Analyst Decision
  • OCS Strong Buy
  • IAUX Buy
  • Analyst Count
  • OCS 4
  • IAUX 1
  • Target Price
  • OCS $41.00
  • IAUX $1.50
  • AVG Volume (30 Days)
  • OCS 99.7K
  • IAUX 5.6M
  • Earning Date
  • OCS 11-06-2025
  • IAUX 11-12-2025
  • Dividend Yield
  • OCS N/A
  • IAUX N/A
  • EPS Growth
  • OCS N/A
  • IAUX N/A
  • EPS
  • OCS N/A
  • IAUX N/A
  • Revenue
  • OCS $960,668.00
  • IAUX $76,622,000.00
  • Revenue This Year
  • OCS $32.89
  • IAUX $81.79
  • Revenue Next Year
  • OCS $1,043.16
  • IAUX $98.01
  • P/E Ratio
  • OCS N/A
  • IAUX N/A
  • Revenue Growth
  • OCS N/A
  • IAUX 40.21
  • 52 Week Low
  • OCS $14.00
  • IAUX $0.34
  • 52 Week High
  • OCS $23.08
  • IAUX $1.15
  • Technical
  • Relative Strength Index (RSI)
  • OCS 43.14
  • IAUX 47.18
  • Support Level
  • OCS $19.00
  • IAUX $0.89
  • Resistance Level
  • OCS $19.63
  • IAUX $0.99
  • Average True Range (ATR)
  • OCS 0.74
  • IAUX 0.05
  • MACD
  • OCS -0.35
  • IAUX -0.01
  • Stochastic Oscillator
  • OCS 6.04
  • IAUX 27.14

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About IAUX i-80 Gold Corp.

i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.

Share on Social Networks: